Spectrofluorimetric determination of guanethidine sulphate,guanfacine hydrochloride,guanoclor sulphate and guanoxan sulphate in tablets and biological fluids,using benzoin

A sensitive and rapid Spectrofluorimetric method for the determination of guanethidine sulphate, guanfacine hydrochloride, guanoclor sulphate and guanoxan sulphate in tablets and spiked human serum and urine samples is described. The method is based on the reaction of monosubstituted guanidino compounds in an aqueous potassium hydroxide solution with benzoin, in the presence of -mercaptoethanol and sodium sulphite. Highly fluorescent derivatives were obtained, with excitation and emission maximum wavelengths around 325 and 430 nm, respectively. In optimal reaction conditions, the linearity ranges were 0.04–0.28 g/ml, with relative standard deviations less than 2%. The method has been successfully applied to the determination of these drugs in tablets. The results are highly correlated with the B.P. method. Chloroform (or for guanoxan dichloromethane) was used to extract the drugs from serum and urine at basic pH, followed by the proposed fluorimetric method. The limit of detection is 0.02 g/ml for the selected drugs.     

Spectrophotometric determination of gold(iii) with p-dimethylaminobenzilidenerhodanine in hydrochloric acid-ethanol medium

The reaction between gold(III) and p-dimethylaminobenzilidenerhodanine in hydrochloric acid medium containing 20% v/v ethanol has been studied spectrophotometrically. It has been established that the process is very complicated: gold(III) is reduced to gold(I) which reacts with unchanged reagent. The value of the equilibrium constant is 2.56 +/- 0.45. Conditions are proposed for the determination of 2-8 mug of gold in 25 ml, with a standard deviation of 0.04 mug 25 ml .     

Katalytische bestimmung von silberspuren in wabetariger lösung und nach extraktion

The application of the catalysed oxidation of Bromopyrogallol Red by potassium per- sulphate for silver determination is discussed. In aqueous solution silver concentrations of 0.5- 1 mug/ml can be determined and 1- 13 ng/ml in the presence of 1, 10-phenanthroline as activator. In combination with solvent extraction, catalytic determination of the extracted silver is possible even in presence of 200 mug of iron(III), cobalt(II) and palladium(II). By means of an automatic variant of the simultaneous comparison method a more sensitive determination (0.2-20 ng/ml) was achieved.     

Recognition and simultaneous determination of ofloxacin enantiomers by synchronization-1st derivative fluorescence spectroscopy

Under controlling pH 3, R-(+)- and S-(-)-ofloxacin (OFLX) enantiomers can be well recognized and resolved by the synchronization-1st derivative fluorescence spectroscopic techniques, and the interference from urine blank also can be eliminated. The linear dynamic ranges are 0.36-2.16 (R), 0.36-2.89 and 3.16-31.6 mug/ml (S), respectively, for determining OFLX in urine samples. The limits of detection are 0.36 mug/ml (R) and the recoveries of R-(+)- and S-(-)-OFLX in urine samples are 97-104%. Relative standard deviation is <6.6%. Pharmacokinetic study of OFLX and levofloxacin shows that R-(+)- and S-(-)-ofloxacin reach their peak concentration in urine samples after a healthy subject has taken tablets for approximately 3 and 6 h, respectively. R-(+)-OFLX can be obviously detected in 5-6 h after a healthy subject has taken tablets, indicating the transformation of S-(-)- to R-(+)-OFLX enantiomer in human body (in vitro).     

Voltammetric determination of benazepril and ramipril in dosage forms and biological fluids through nitrosation

A simple and highly sensitive voltammetric method was developed for the determination of benazepril (I) and ramipril (II). The compounds were treated with nitrous acid, and the cathodic current produced by the resulting nitroso derivatives was measured. The voltammetric behavior was studied by adopting direct current (DCt), differential pulse (DPP), and alternating current (ACt) polarography. Both compounds produced well-defined, diffusion-controlled cathodic waves over the whole pH range in Britton-Robinson buffers (BRb). At pH 3 and 5, the values of diffusion-current constants (Id), were 5.90 +/- 0.40 and 6.66 +/- 0.61 for I and II, respectively. The current concentration plots for I were rectilinear over the range of 1.5-40 and 0.1-30 microg/mL in the DCt and DPP modes, respectively; for II, the range was 2-30 and 0.1-20 microg/mL in the DCt and DPP modes, respectively. The minimum detectabilities (S/N = 2) were 0.015 microg/mL (about 3.25 x 10(-8)M) and 0.012 microg/mL (about 2.88 x 10(-8)M) for I and II, respectively, adopting the DPP mode. Results obtained for the proposed method when applied to the determination of both compounds in dosage forms were in good agreement with those obtained using reference methods. Hydrochlorthiazide, which is frequently co-formulated with these drugs, did not interfere with the assay. The method was also applied to the determination of benazepril in spiked human urine and plasma. The percentage recoveries adopting the DPP mode were 96.2 +/- 1.21 and 95.7 +/- 1.61, respectively.     

Spectrophotometric determination of four macrolide antibiotics in pharmaceutical formulations and biological fluids via binary complex formation with eosin [corrected

A simple, rapid, and sensitive validated spectrophotometric method was developed for the determination of certain macrolide antibiotics namely, erythromycin (I), azithromycin dihydrate (II), clarithromycin (III), and roxithromycin (IV) in bulk powders, pharmaceutical formulations, and spiked biological fluids. The proposed method is based on the formation of a binary complex between each of the studied drugs and eosin Y in aqueous buffered medium. Under the optimum conditions, the binary complexes showed absorption maxima at 542-544 nm. The absorbance of the binary complexes obeyed Beer's law over the concentration range of 1-10 micro/g/mL for II, 2-20 microg/mL for I and IV, and 3-30 microg/mL for III. The mean percentage recoveries were 100.04 +/- 0.83, 99.98 +/- 0.80, 100.17 +/- 0.91, and 99.55 +/- 0.91, with minimum detectable molarities of 2 x 10(-7) for I and II, 4 x 10(-7) for III, and 3 x 10(-7) for IV. The different experimental parameters affecting the development and stability of the colors were studied and optimized. The proposed method was successfully applied to the analysis of the cited drugs in some pharmaceutical formulations. The results obtained were in good agreement with those obtained using the reference methods. The proposed method was further applied to spiked human urine and plasma. A proposal of the reaction pathway is suggested.     

The use of phenylfluorone in the presence of cetylpyridinium chloride and Triton X-100 for the spectrophotometric determination of copper(II) in blood serum

A simple and sensitive spectrophotometric method for determination of copper(II) is based on the formation of a blue coloured complex of Cu(II) with 9-phenyl-2,3,7-trihydroxy-6-fluorone (PF) in the presence of cetylpyridinium chloride (CP) and Triton X-100, has been developed. Optimum concentrations of PF, CP, Triton X-100 and pH ensuring maximum absorbance were defined. The complex Cu(II)-PF-CP-Triton X-100 shows maximum absorbance at 595 nm with a molar absorptivity value of 9.67x10(4) l mol(-1) cm(-1). The detection limit of the method is 0.028 mug ml(-1). Beer's law is obeyed for copper concentrations in the range 0.04-0.4 mug ml(-1). The studies of the effect of foreign ions on determination of copper, show that the selectivity of the method is poor. The cations of alkali metals and anions Br(-), Cl(-), I(-), F(-), NO(2)(-), NO(3)(-), CH(3)COO(-), SO(4)(2-), S(2)O(3)(2-), PO(4)(3-), citrates (examined in 1000-fold molar excess over copper) do not affect the determination. All cations forming complexes with PF have an interfering effect. The statistical evaluation of the method was carried out for six determinations using 10 mug of Cu and the following results were obtained: the standard deviation, SD=0.042, the confidence interval mu(95)=10.1+/-0.1 mug Cu. The method has been applied for determination of copper in blood serum.     

Fluorimetric determination of sulphate by ternary complex formation with zirconium and biacetylmonoxime nicotinylhydrazone

A fluorimetric procedure for the determination of sulphate (0.5-6 mug ml ) based on the formation of a ternary complex with biacetylmonoxime nicotinylhydrazone and zirconium(IV) is described. The excitation and fluorescence maxima are at 415 and 505 nm, respectively. The method is rapid and the procedure reproducible. The precision is +/- 2% near to the middle range of the calibration curves. There is no interference from most common ions. Phosphate and fluoride are tolerated at 100-fold molar ratio to sulphate. The method has been applied to the determination of sulphate in a variety of water samples.     

A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate in pharmaceutical preparations

A simple spectrophotometric method for the determination of nylidrin hydrochloride, isoxsuprine hydrochloride and salbutamol sulphate is described, based on measurement of the orangeyellow species produced when the drugs are coupled with diazotized benzocaine (p-aminoethyl benzoate) in trimethylamine medium. The method is applicable over the range 1-12 mug ml for isoxsuprine hydrochloride and nylidrin hydrochloride and 1-8 mug ml for salbutamol sulphate. The method is a modification of the Bratton-Marshall reaction and is simple, reproducible, accurate and more sensitive than those cited in the literature.     

Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients.

CPT-11 (I; 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin) is a new anticancer agent currently under clinical development. A sensitive high-performance liquid chromatographic assay suitable for the simultaneous determination of I and its active metabolite SN-38 (II) in human plasma, and their preliminary clinical pharmacokinetics, are described. Plasma samples were processed using a solid-phase (C18) extraction step allowing mean recoveries of I, II and the internal standard camptothecin (III) of 84, 99 and 72%, respectively. The extracts were chromatographed on a C18 reversed-phase column with a mobile phase composed of acetonitrile, phosphate buffer and heptanesulphonic acid, with fluorescence detection. The calibration graphs were linear over a wide range of concentrations (1 ng/ml-10 micrograms/ml), and the lower limit of determination was 1 ng/ml for both I and II. The method showed good precision: the within-day relative standard deviation (R.S.D.) (5-1000 ng/ml) was 13.0% (range 4.9-19.4%) for I and 12.8% (6.7-19.1%) for II; the between-day R.S.D. (5-10,000 ng/ml was 7.9% (5.4-17.5%) for I and 9.7% (3.5-15.1%) for II. Using this assay, plasma pharmacokinetics of both I and II were simultaneously determined in three patients receiving 100 mg/m2 I as a 30-min intravenous infusion. The mean peak plasma concentration of I at the end of the intravenous infusion was 2400 +/- 285 ng/ml (mean +/- standard error of the mean). Plasma decay was triphasic with half-lives alpha, beta and gamma of 5.4 +/- 1.8 min, 2.5 +/- 0.5 h and 20.2 +/- 4.6 h, respectively. The volume of distribution at steady state was 105 +/- 15 l/m2, and the total body clearance was 12.5 +/- 1.9 l/h.m2. The maximum concentrations of the active metabolite II reached 36 +/- 11 ng/ml.     

Heterocyclic dithiophosphates as analytical reagents Indirect extraction-spectrophotometric determination of silver in copper concentrates and ores

The proposed method is based on the exchange reaction between the complex of copper(II) with 4,7-dimethyl-2-thiol-2-thion-1,3,2-dioxophosphorinan (DOPh(III)) in toluene and an aqueous solution of silver(I). The decrease in the absorbance of the Cu(DOPh(III))(2) solution is proportional to the silver(I) concentration for 5-90 mug of silver in 5 ml of toluene extract and 5-30 mug in 10 ml of toluene extract. The method is applied to the determination of silver in copper concentrates and ores.     

Determination of dextromethorphan and metabolites in human plasma and urine by high-performance liquid chromatography with fluorescence detection

Sensitive methods were developed for the analysis of dextromethorphan (I) and two metabolites, (+)-17-methyl-morphinan-3-ol (II) and (+)-morphinan-3-ol (III), in plasma as well as dextromethorphan and three metabolites II, III and (+)-3-methoxymorphinan (IV) in urine using high-performance liquid chromatography followed by detection with a fluorometer. Dextromethorphan and its metabolites were extracted from plasma and urine and separated in the reversed-phase mode. The practical lower limits of determination for I, II, and III in plasma were 0.5, 5, and 5 ng/ml, respectively; for I, II, III, and IV in urine, the limits were 20 ng/ml, 0.6 microgram/ml, 0.5 microgram/ml, and 15 ng/ml, respectively. The linearity of the calibration graphs was excellent (r varied from 0.9994 to 0.9999) over concentration ranges of two orders of magnitude.     

Spectrofluorimetric determination of drugs containing active methylene group using N1-methyl nicotinamide chloride as a fluorigenic agent

A spectrofluorimetric method was described for the determination of drugs containing active methylene groups adjacent to carbonyl groups. The method was applied successfully to the determination of three life saving cardiovascular drugs, with narrow therapeutic indices: pentoxifylline (I), propafenone hydrochloride (II) and acebutolol hydrochloride (III), in laboratory-prepared mixtures, in commercial tablets and in plasma samples. The method involved the reaction of each of the tested drugs with N1-methyl nicotinamide chloride (NMNCl) in the presence of alkali, followed by addition of formic acid, where highly fluorescent reaction products were produced. The produced fluorescence were measured quantitatively at 472 nm (lambdaex 352 nm), 409 nm (lambdaex 310 nm) and 451 nm (lambdaex 266 nm) for (I), (II), and (III) respectively. The method was linear over concentration ranges of 10-1000 microg/ml , 0.2-12 microg/ml and 0.08-10 microg/ml in standard solutions for (I), (II), and (III) respectively. In spiked human plasma samples, calibration graphs were linear over concentration ranges of 20-1000 microg/ml, 0.2-15 microg/ml and 0.08-10 microg/ml for (I), (II), and (III) respectively. The method showed good accuracy, specificity and precision in both laboratory-prepared mixtures and spiked human plasma samples. The proposed method is simple, with low instrumentation requirements, suitable for quality control application, bioavailability and bioequivalency studies.     

Spectrophotometric determination of some drugs for osteoporosis

Three simple, accurate and sensitive spectrophotometric methods are developed for the determination of some new drugs for the treatment of osteoporosis: risedronate sodium (I), alendronate sodium (II) and etidronate disodium (III). The first method is based on the measurement of difference in absorbance (Delta A) of risedronate sodium in 0.01 mol l(-1) hydrochloric and 0.1 mol l(-1) sodium hydroxide at 262 nm. Beer's law is obeyed over a concentration range of 15-150 microg ml(-1) with mean recovery 99.75+/-1.22 and molar absorptivity (epsilon) 1.891 x 10(3). The second method is based on the reaction of the primary amino group of (II) with ninhydrin reagent in methanolic medium in the presence of 0.05 mol l(-1) sodium bicarbonate. The colored product is measured at 568 nm, and the linearity range is found to be 3.75-45 microg ml(-1) with mean recovery 99.77+/-0.73 and epsilon 9.425 x 10(3). The third method is based on oxidation of the three mentioned drugs with ceric (IV) sulphate in 0.5 mol l(-1) sulphuric acid at room temperature and subsequent measurement of the excess unreacted cerium (IV) sulphate at 320 nm. The method obeyed Beer's law over a concentration range of 2-24 microg ml(-1) for the three drugs with mean recovery 99.79+/-1.16, 99.73+/-1.38 and 99.86+/-1.13 and epsilon 14.427 x 10(3), 13.813 x 10(3) and 14.000 x 10(3) for drugs I, II, III respectively. The proposed methods were successfully applied for the determination of the studied drugs in bulk powder and in pharmaceutical formulations. The results were found to agree statistically with those obtained the reported methods. Furthermore, the methods were validated according to USP regulations and also assessed by applying the standard addition technique.     

Spectrophotometric and chromatographic determination of sulfanilamides in biological fluids and pharmaceuticals

The conditions for the determination of norsulfazol (I), sulfadimezine (II), ethazole (III), sulfamethoxypyridazine (IV), sulfadimethoxine (V), sodium sulfacyl (VI), sulfalene (VII), sulgin (VIII), and bucarban (IX) as their derivatives of 4,6-dinitrobenzofuroxan using spectrophotometry and thin-layer chromatography were selected. The best results were obtained at 490–500 nm using polar solvents and their aqueous mixtures of pH 6.68 as analytical media. The analytical range for sulfanilamides was 0.5–6.0 Μg/mL. The limits of detection (Μg/mL) were 0.24 for 1,0.28 for II, 0.43 for III, 0.18 for IV, 0.25 for V, 0.54 for VI, 0.54 for VII, 0.17 for VII, and 0.31 for IX. Sulfanilamides were determined in Pharmaceuticals (tablets, ointments, and drops) and biological fluids (protein hydrolyzates, urine, blood serum, and whole blood). A simple rapid method for the determination of the phenotype of biotransformation by the type of acetylation was developed based on the studies of the kinetics of the excretion of II from the human body with urine.     

Determination of a ternary mixture of penicillin-G sodium salt, penicillin-G procain salt and dihydrostreptomycin sulphate, by third-derivative spectrophotometry

Ternary mixtures of antibiotics, i.e. penicillin-G sodium salt, penicillin-G procain salt and dihydrostreptomycin sulphate salt, are assayed by 'zero-crossing' third-derivative spectrophotometry. Calibration plots follows Beer's law up to 40 mug/ml of penicillin-G sodium at 222.5 nm (r = 0.9997), 46 mug/ml of penicillin-G procain at 217 nm (r = 0.9999) and 36 mug/ml of dihydrostreptomycin sulphate at 211.5 nm (r = 0.9999), in the presence of one another. Detection limits at p = 0.05 level of significance were calculated to be, respectively, 0.66, 0.41 and 0.25 mug/ml. The procedure is rapid, simple, nondestructive and does not require solution of equations. The method was successfully applied for determining laboratory mixtures and commercial injections.     

Kinetic determination of Hg(II) in different materials, based on its inhibitory effect on a catalysed process

A new kinetic method for the determination of Hg(II) based on its inhibitory effect on the Pd(II)-catalysed reaction between Co(III)-EDTA and hypophosphite is proposed. The reaction is followed spectrophotometrically at 540 nm by measuring the induction period. Both the influence of the reaction variables and the interference of many ions have been studied. A mechanism for the inhibition process is also proposed. Under the selected experimental conditions of 2.7 x 10(-1)M Co(III)-EDTA, pH-3.2 Britton-Robinson buffer, 0.3M H(2)PO(-)(2), 0.35 mug/ml Pd(II), and temperature 18 +/- 0.2 degrees , Hg(II) was determined in the range 13-120 ng/ml. The method was applied to the determination of Hg(II) in sphalerites and pharmaceuticals.     

High-performance liquid chromatographic assay of pirlimycin in human serum and urine using 9-fluorenylmethylchloroformate

A reversed-phase high-performance liquid chromatographic (HPLC) assay method has been developed for determining pirlimycin in human serum and urine. The method involves chloroform extraction of pirlimycin free base followed by derivatization with 9-fluorenylmethylchloroformate to form a carbamate ester. The reaction is rapid, reproducible, and quantitative. 9-Fluorenylmethylchloroformate reacts with amines to form derivatives sensitive to both ultraviolet and fluorescence detection. Human serum and urine samples following 50-mg and 500-mg single oral doses of pirlimycin were analyzed. The samples were chromatographed on an RP-18 Spherisorb 5-micron, 250 X 4.6 mm I.D. reversed-phase HPLC column. The eluent for the serum assay was acetonitrile-water (58:42) containing 0.02% acetic acid, and for the urine assay was acetonitrile-methanol-tetrahydrofuran-water (48:2:1:49). Fluoranthene was used as an internal standard. The assay sensitivity by ultraviolet detection (lambda max = 264) was about 5 ng/ml and by fluorescence detection (lambda excitation = 270 nm, lambda emission = 300 nm) was 0.1 ng/ml. Statistical analysis indicates an average drug recovery of 101 +/- 4.2% from serum and 102.0 +/- 2.62% from urine.     

Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products

A simple sensitive, selective and accurate reversed-phase high performance liquid chromatographic method was developed and validated for the quantitative determination of lansoprazole, omeprazole and pantoprazole sodium sesquishydrate in the presence of their acid-induced degradation products. The three compounds were monitored at 280 nm using Nova-Pak C(18) column and a mobile phase consisting of 0.05 M potassium dihydrogen phosphate : methanol : acetonitrile (5 : 3 : 2 v/v/v). Linearity ranges were 2-20 mug ml(-1), 2-36 mug ml(-1) and 0.5-20 mug ml(-1) for lansoprazole, omeprazole and pantoprazole, respectively. The corresponding recoveries were 100.61+/-0.84%, 100.50+/-0.80% and 99.78+/-0.88%. The minimum detection limits were 0.55, 0.54 and 0.03 mug ml(-1) for lansoprazole, omeprazole and pantoprazole, respectively. The method could be successfully applied to the determination of pure, laboratory prepared mixtures and pharmaceutical dosage forms. The results obtained were compared with the reported methods for lansoprazole and pantoprazole or the official U.S.P method for omeprazole.     

Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma

Four sensitive, simple and specific methods were developed for the determination of desloratadine (DSL), a new antihistaminic drug in pharmaceutical preparations and biological fluids. Methods I and II are based on coupling DSL with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) in borate buffer of pH 7.6 where a yellow colored reaction product was obtained and measured spectrophotometrically at 485 nm (Method I). The same product could be measured spectrofluorometrically at 538 nm after excitation at 480 nm (Method II). Methods III and IV, on the other hand, involved derivatization of DSL with 2,4-dinitrofluorobenzene (DNFB) in borate buffer of pH 9.0 producing a yellow colored product that absorbs maximally at 375 nm (Method III). The same derivative was determined after separation adopting HPLC (Method IV). The separation was performed on a column packed with cyanopropyl bonded stationary phase equilibrated with a mobile phase composed of acetonitrile-water (60 : 40, v/v) at a flow rate of 1.0 ml min(-1) with UV detection at 375 nm. The calibration curves were linear over the concentration ranges of 0.5-6, 0.02-0.4, 1-10 and 1-30 microg ml(-1) for Methods I, II, III and IV, respectively. The lower detection limits (LOD) were 0.112, 0.004, 0.172 and 0.290 microg ml(-1), respectively, for the four methods. The limits of quantification (LOQ) were 0.340, 0.012, 0.522 and 0.890 microg ml(-1) for Methods I, II, III and IV, respectively. The proposed methods were applied to the determination of desloratadine in its tablets and the results were in agreement with those obtained using a reference method. Furthermore, the spectrofluorometric method (Method II) was extended to the in-vitro determination of the drug in spiked human plasma, with a mean percentage recovery (n=4) of 99.7+/-3.54. Interference arising from endogenous amino acids has been overcome using solid phase extraction. The proposed methods are highly specific for determination of DSL in the presence of the parent drug loratadine. A proposal for the reaction pathways is postulated.